Search - tctmd.com

Displaying 21 - 40 of 2778

Sort: Relevancy | Date

News Daily News

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Caitlin E. Cox

November 24, 2025

News Daily News

Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis

Todd Neale

November 21, 2025

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

Caitlin E. Cox

November 21, 2025

News Industry News

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

November 19, 2025

News Conference News AHA 2025

Beta-blockers Not Helpful After MI in Patients With Preserved EF

Yael L. Maxwell

November 12, 2025

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Conference News AHA 2025

Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP

Caitlin E. Cox

November 10, 2025

News Conference News AHA 2025

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

Todd Neale

November 09, 2025

News Conference News AHA 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Todd Neale

November 08, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2025

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 1021: Incidence and Outcomes of Hospitalized Acute Ischemic Stroke Patients with subsequent ST-Segment-Elevation Myocardial Infarction

Presenter: Arhum Mahmood

October 28, 2025

Presentation TCT 2025

TCT 1015: External Validation of the xDAPT Machine Learning Model for Ischemic and Bleeding Risk After Percutaneous Coronary Intervention

Presenter: Davide Cao

October 28, 2025

Presentation TCT 2025

TCT 553: Comparative Outcomes of Ischemic vs Non-Ischemic Cardiomyopathy in Left Ventricular Assist Device Recipients: A National Readmission Analysis

Presenter: Junaid Mir

October 28, 2025

Presentation TCT 2025

TCT 1010: Long‑Term Prognostic Significance of High Ischemic versus High Bleeding Risk Phenotypes After Percutaneous Coronary Intervention: HOST-EXAM Extended Study Post Hoc Analysis

Presenter: Jin-Eun Song

October 27, 2025

Presentation TCT 2025

TCT 1000: Time Course of Ischemic and Bleeding Complications in Patients With Acute Coronary Syndrome Managed Invasively

Presenter: Fiorenzo Simonetti

October 27, 2025

Presentation TCT 2025

TCT 400: Mortality Trends in Acute Myocardial Infarction With Chronic Ischemic Heart Disease: CDC WONDER Data Analysis, 1999–2020

Presenter: Hriday Shah

October 27, 2025

Presentation TCT 2025

TCT 997: Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis

Presenter: Jin-Eun Song

October 27, 2025

Presentation TCT 2025

TCT 296: 25-Year Trends in Postoperative Mortality in U.S. Adults with Ischemic Heart Disease

Presenter: Zeyad Kholeif

October 27, 2025

Advertisement

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

Beta-blockers Not Helpful After MI in Patients With Preserved EF

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

TCT 1021: Incidence and Outcomes of Hospitalized Acute Ischemic Stroke Patients with subsequent ST-Segment-Elevation Myocardial Infarction

TCT 1015: External Validation of the xDAPT Machine Learning Model for Ischemic and Bleeding Risk After Percutaneous Coronary Intervention

TCT 553: Comparative Outcomes of Ischemic vs Non-Ischemic Cardiomyopathy in Left Ventricular Assist Device Recipients: A National Readmission Analysis

TCT 1010: Long‑Term Prognostic Significance of High Ischemic versus High Bleeding Risk Phenotypes After Percutaneous Coronary Intervention: HOST-EXAM Extended Study Post Hoc Analysis

TCT 1000: Time Course of Ischemic and Bleeding Complications in Patients With Acute Coronary Syndrome Managed Invasively

TCT 400: Mortality Trends in Acute Myocardial Infarction With Chronic Ischemic Heart Disease: CDC WONDER Data Analysis, 1999–2020

TCT 997: Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis

TCT 296: 25-Year Trends in Postoperative Mortality in U.S. Adults with Ischemic Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content